Bay Area Mystery Company Adicet bio Plans to Hire 35 People Over Next 5 Years

December 11, 2015
By Mark Terry, BioSpace.com Breaking News Staff

South San Francisco-based Adicet Bio Inc. has plans to move its headquarters and hire another 36 more people over the next five years.

Not much is publicly known about Adicet Bio. Its original filing headquarters were in New York, NY, with the company’s president and chief executive officer cited as Aya Jakobovits. The company was founded in 2014. It apparently is working in the oncology arena and employs four people.

In August 2015, the company filed form D with the U.S. Securities Exchange Commission (SEC) and indicated it was filing for $40 million in equity financing. At that time, it indicated it had $14.63 million raised.

As part of the company’s change it headquarters to 200 Constitution Drive in South San Francisco, it applied for a use permit to storage and use hazardous materials, which were granted unanimously. A public hearing was conducted and the company’s vice president for product development, Andy Lin, was asked by Chairman John Onken of the city’s zoning board, if there was anything he would lose sleep over in terms of the hazardous materials. Lin indicated that he didn’t, other than an existing “diesel generator in back for emergency power; that’s probably the biggest concern I have. … Other than that, the chemicals on site are fairly benign and in low quantities.”

Aya Jakobovits is a venture partner with OrbiMed Advisors. She previously served as president and founding chief executive officer of Kite Pharma, Inc. She also held several director and executive-level jobs at other biotech companies, including Cell Genesys, Inc., Abgenix, Inc. and Agensys, Inc.

When Jakobovits was contacted by BioSpace for more information, she said the company is not yet in the public domain and could not release more information, including what the company’s focus is.